期刊文献+

^(99m)Tc-depreotide与人肺腺癌A549细胞生长抑素受体结合实验

Observation on ^(99m)Tc-depreotide with somatostatin receptor of pulmonary adenocarcinoma A549 cells
下载PDF
导出
摘要 目的:通过99mTc-depreotide与人肺腺癌A549细胞结合的体外实验,评价99mTc-depreotide作为肿瘤生长抑素受体显像剂的可能性。方法:采用受体放射分析法,分别在4、25和37℃条件下观察温度对A549细胞摄取99mTc-depreotide的影响。在4和37℃条件下培养A549细胞,并于不同时间点计算99mTc-depreotide在A549细胞内的滞留率,同时计算半清除时间。将A549细胞与99mTc-depreotide在37℃条件下分别孵育不同时间,分析肿瘤细胞对99mTc-depreotide的内化率和细胞膜表面结合率的变化。结果:在相同时间点,摄取率随温度升高逐渐增加,证明其摄取存在温度依赖性;在37℃条件下,摄取峰时为60min。A549细胞对99mTc-depreotide的清除速度不依赖于温度,37℃条件下的半清除时间为48 min。37℃条件下,99mTc-depreotide在A549细胞内发生特异性内化,内化活性随时间延长而逐渐增加。结论:A549细胞能够特异性结合99mTc-depreotide,在37℃条件下表现出适于受体显像的摄取峰值时间和半清除时间。 Objective:Observation on 99mTc-depreotide with somatostatin receptor of human pulmonary adenocarcinoma A549 cells in vitro in order to evaluate the potentiality of 99mTc-depreotide as a somatostatin receptor imaging agent.Methods:Using receptor radioligand binding assay,this work observed the effect of temperature on the uptake of 99mTc-depreotide by A549 cells at 4,25,and 37 ℃.A549 cells were cultured at 4 and 37 ℃ and stagnation ratio of 99mTc-depreotide in A549 cells and the half clearance time were calculated at different time points.A549 cells were incubated with 99mTc-depreotide at 37 ℃ for various times.The changes in the internalization and surface-bound activity of 99mTc-depreotide with A549 cells were analyzed.Results:The uptake index increased with the increasing temperatures at the same time point,demonstrating that the uptake was temperature-dependent.The peak time for maximum uptake was 60 min at 37℃.The cleaning speed of 99mTc-depreotide by A549 cells did not depend on temperature,and the half cleaning time was 48 min at 37℃.At 37℃,99mTc-depreotide had specific internalization in A549 cells,and the internalization activity gradually increased when the time was prolonged.Conclusion:A549 cells have specific binding with 99mTc-depreotide,and exhibits peak time of maximum uptake and half cleaning time for receptor imaging at 37℃.
出处 《肿瘤》 CAS CSCD 北大核心 2009年第9期860-863,共4页 Tumor
基金 上海市卫生局科技发展基金资助项目(编号:054035)
关键词 肺肿瘤 腺癌 地普奥肽 生长抑素 细胞 A549 Lung neoplasms Adenocarcinoma Technetium Depreotide Somatostatin Cell A549
  • 相关文献

参考文献5

  • 1BLUM JE, HANDMAKER H, RINNE NA, et al. Technetium labeled small peptide radiopharmaceuticals in the identification of lung cancer[ J]. Curr Pharm Des, 2002, 8 (20) 1827-1836.
  • 2CYR JE, PEARSON D A, NELSON C A, et al. Isolation, characterization, and biological evaluation of syn and anti diastereomers of [ (99m) Tc ] technetium depreotide: a somatostatin receptor binding tumor imaging agent [J]. J Med Chem, 2007,50 (18):4295-4303.
  • 3王磊,刘海林,霍立.生长抑素受体亚型介导人肝癌细胞凋亡的实验研究[J].肿瘤,2005,25(3):232-235. 被引量:2
  • 4VAN DEN BOSSCHE B, VAN BELLE S, DE WINTER F, et al. Early prediction of endocrine therapy effect in advanced breast cancer patients using ^99mTc-depreotide scintigraphy [ J ]. J Nucl Med, 2006, 47(11) :6-13.
  • 5VIRGOLINI I, LEIMER M, HANDMAKER H, et al. Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, ^99mTc-P829[J]. Cancer Res, 1998, 58(9) :1850-1859.

二级参考文献14

  • 1Diaconu CC, Szathmari M, Keri G, et al. Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232[J]. Br J Cancer, 1999,80 : 1197-1203.
  • 2Nakaizumi A, Uehara H, Baba M, et al. Inhibition by somatostatin of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats [ J ]. Carcinogenesis, 1993, 14:2601-2604.
  • 3Davies N, Yates J, Kynaston H, et al. Effects of octreotide on liver regeneration and tumour growth in the regenerating liver[J]. J Gastroenterol Hepatol, 1997,12: 47-53.
  • 4Schindel DT, Grosfeld JL. Hepatic resection enhances growth of residual intrahepatic and subcutaneous hepatoma, which is inhibited by octreotide[J]. J Pediatr Surg, 1997, 32: 995-998.
  • 5Slooter GD, Breeman WA, Marquet RL, et al. Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver[J]. Int J Cancer, 1999,81 : 767-771.
  • 6Reubi JC, Zimmermann A, Jonas S, et al. Regulatory peptide receptors in human hepatocellular carcinomas[J]. Gut,1999,45: 766-774.
  • 7Rabinowitz I, Telepak R, Lee FC. et al. Octreotide scans are positive in a subset of patients with hepatocellular carcinoma [J]. Clin Nucl Med, 2002,27: 499-502.
  • 8Sharma K, Patel YC, Srikant CB. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest,by human somatostatin receptor 3 [J]. Mol Endocrinol,1996,10: 1688-1696.
  • 9Teijeiro R, Rios R, Costoya JA, et al. Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53[J]. Cell Physiol Biochem, 2002,12: 31-33.
  • 10Kouroumalis E, Skordilis P, Thermos K, et al. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study[J]. Gut, 1998,42 : 442-447.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部